Madhumati Singh 1 , Giriraj Sandeep Gonegandla 1 Show Affiliations »
Abstract
INTRODUCTION: The risk of osteonecrosis of the jaw is greater for patients receiving intravenous bisphosphonates for cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget's disease. MATERIALS AND METHODS: This article provides a review of the treatment of Bisphosphonate induced osteonecrosis of jaws. CONCLUSION: Bisphonates associated jaw necrosis and its relation to dentisitry and maxillofacial surgery has become common now a days. Proper diagnosis and treatment may help the patients health getting worsen. © The Association of Oral and Maxillofacial Surgeons of India 2019.
INTRODUCTION: The risk of osteonecrosis of the jaw is greater for patients receiving intravenous bisphosphonates for cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget's disease. MATERIALS AND METHODS: This article provides a review of the treatment of Bisphosphonate induced osteonecrosis of jaws. CONCLUSION: Bisphonates associated jaw necrosis and its relation to dentisitry and maxillofacial surgery has become common now a days. Proper diagnosis and treatment may help the patients health getting worsen. © The Association of Oral and Maxillofacial Surgeons of India 2019.
Entities: Chemical
Keywords:
BIONJ; Bisphosphonate-induced osteonecrosis; Bisphosphonate-related osteonecrosis; Bisphosphonates in maxillofacial surgery
Year: 2019
PMID： 32346224 PMCID： PMC7176749 DOI： 10.1007/s12663-019-01211-2
Source DB: PubMed Journal: J Maxillofac Oral Surg ISSN： 0972-8270